US Stock MarketDetailed Quotes

ELDN Eledon Pharmaceuticals

Watchlist
  • 3.610
  • +0.100+2.85%
Close Mar 24 16:00 ET
  • 3.640
  • +0.030+0.83%
Post 17:00 ET
216.17MMarket Cap-4.81P/E (TTM)

Eledon Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
64.13%70.58M
138.89%24.7M
83.16%20.51M
40.06%14.5M
-2.17%10.87M
8.09%43M
2.97%10.34M
5.66%11.2M
11.54%10.35M
12.69%11.11M
Selling and administrative expenses
46.70%18.61M
106.91%6.77M
22.13%3.99M
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
-General and administrative expense
46.70%18.61M
106.91%6.77M
22.13%3.99M
39.42%4.4M
15.42%3.46M
-0.09%12.69M
17.24%3.27M
3.85%3.27M
-10.93%3.15M
-7.04%3M
Research and development costs
71.43%51.96M
153.69%17.93M
108.30%16.52M
40.34%10.11M
-8.67%7.41M
11.94%30.31M
-2.52%7.07M
6.43%7.93M
25.39%7.2M
22.28%8.11M
Operating profit
-64.13%-70.58M
-138.89%-24.7M
-83.16%-20.51M
-40.06%-14.5M
2.17%-10.87M
-8.09%-43M
-2.97%-10.34M
-5.66%-11.2M
-11.54%-10.35M
-12.69%-11.11M
Net non-operating interest income expense
Other net income (expense)
147.36%34.82M
1.37%-19.49M
7,444.97%97.48M
45.12%-30.41M
-3,875.74%-12.76M
-52.61%-73.54M
59.12%-19.76M
917.32%1.29M
-154,005.56%-55.41M
6,860.00%338K
Gain on sale of security
140.55%30.9M
-2.23%-20.93M
21,669.53%96.44M
44.33%-31.27M
---13.34M
---76.21M
---20.47M
--443K
---56.18M
----
Other non- operating income (expenses)
46.75%3.92M
102.11%1.44M
22.73%1.04M
12.13%869K
69.82%574K
478.79%2.67M
134.21%712K
568.50%849K
2,052.78%775K
6,860.00%338K
Income before tax
69.32%-35.75M
-46.80%-44.19M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
Income tax
431K
0
Net income
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
Net income continuous Operations
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
Minority interest income
Net income attributable to the parent company
68.95%-36.18M
-48.23%-44.62M
877.01%76.97M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
Preferred stock dividends
Other preferred stock dividends
22.54M
0
Net income attributable to common stockholders
68.95%-36.18M
-38.66%-41.74M
649.45%54.43M
31.71%-44.91M
-119.37%-23.63M
-32.48%-116.54M
48.45%-30.1M
5.40%-9.91M
-611.15%-65.76M
-9.21%-10.77M
Basic earnings per share
84.14%-0.75
6.38%-0.88
418.18%1.05
61.31%-1.06
-5.33%-0.79
23.21%-4.73
77.02%-0.94
54.79%-0.33
-321.54%-2.74
-8.70%-0.75
Diluted earnings per share
84.14%-0.75
6.38%-0.88
3.03%-0.32
61.31%-1.06
-5.33%-0.79
23.21%-4.73
77.02%-0.94
54.79%-0.33
-321.54%-2.74
-8.70%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 64.13%70.58M138.89%24.7M83.16%20.51M40.06%14.5M-2.17%10.87M8.09%43M2.97%10.34M5.66%11.2M11.54%10.35M12.69%11.11M
Selling and administrative expenses 46.70%18.61M106.91%6.77M22.13%3.99M39.42%4.4M15.42%3.46M-0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M
-General and administrative expense 46.70%18.61M106.91%6.77M22.13%3.99M39.42%4.4M15.42%3.46M-0.09%12.69M17.24%3.27M3.85%3.27M-10.93%3.15M-7.04%3M
Research and development costs 71.43%51.96M153.69%17.93M108.30%16.52M40.34%10.11M-8.67%7.41M11.94%30.31M-2.52%7.07M6.43%7.93M25.39%7.2M22.28%8.11M
Operating profit -64.13%-70.58M-138.89%-24.7M-83.16%-20.51M-40.06%-14.5M2.17%-10.87M-8.09%-43M-2.97%-10.34M-5.66%-11.2M-11.54%-10.35M-12.69%-11.11M
Net non-operating interest income expense
Other net income (expense) 147.36%34.82M1.37%-19.49M7,444.97%97.48M45.12%-30.41M-3,875.74%-12.76M-52.61%-73.54M59.12%-19.76M917.32%1.29M-154,005.56%-55.41M6,860.00%338K
Gain on sale of security 140.55%30.9M-2.23%-20.93M21,669.53%96.44M44.33%-31.27M---13.34M---76.21M---20.47M--443K---56.18M----
Other non- operating income (expenses) 46.75%3.92M102.11%1.44M22.73%1.04M12.13%869K69.82%574K478.79%2.67M134.21%712K568.50%849K2,052.78%775K6,860.00%338K
Income before tax 69.32%-35.75M-46.80%-44.19M877.01%76.97M31.71%-44.91M-119.37%-23.63M-32.48%-116.54M48.45%-30.1M5.40%-9.91M-611.15%-65.76M-9.21%-10.77M
Income tax 431K0
Net income 68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M-32.48%-116.54M48.45%-30.1M5.40%-9.91M-611.15%-65.76M-9.21%-10.77M
Net income continuous Operations 68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M-32.48%-116.54M48.45%-30.1M5.40%-9.91M-611.15%-65.76M-9.21%-10.77M
Minority interest income
Net income attributable to the parent company 68.95%-36.18M-48.23%-44.62M877.01%76.97M31.71%-44.91M-119.37%-23.63M-32.48%-116.54M48.45%-30.1M5.40%-9.91M-611.15%-65.76M-9.21%-10.77M
Preferred stock dividends
Other preferred stock dividends 22.54M0
Net income attributable to common stockholders 68.95%-36.18M-38.66%-41.74M649.45%54.43M31.71%-44.91M-119.37%-23.63M-32.48%-116.54M48.45%-30.1M5.40%-9.91M-611.15%-65.76M-9.21%-10.77M
Basic earnings per share 84.14%-0.756.38%-0.88418.18%1.0561.31%-1.06-5.33%-0.7923.21%-4.7377.02%-0.9454.79%-0.33-321.54%-2.74-8.70%-0.75
Diluted earnings per share 84.14%-0.756.38%-0.883.03%-0.3261.31%-1.06-5.33%-0.7923.21%-4.7377.02%-0.9454.79%-0.33-321.54%-2.74-8.70%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion with Explanatory Notes--------

Market Insights

U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
CleanSpark
CLSK
8.790
MARA Holdings
MARA
14.610
Bitdeer Technologies
BTDR
11.650
4
Bakkt Holdings
BKKT
13.830
5
Canaan
CAN
1.070
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings